Frost & Sullivan releases the 'White Paper on the Current State and Development Trends of Tumor-Infiltrating Lymphocyte (TIL) Therapies'

Frost & Sullivan (Frost & Sullivan, abbreviated as 'Frost & Sullivan') hereby publishes the 'White Paper on the Current Situation and Development Trends of Tumor-Infiltrating Lymphocyte (TIL) Therapy Industries', aiming to conduct a comprehensive and in-depth analysis of the TIL therapy industry. It explores the driving factors behind industry development from multiple aspects such as policies and regulations, industrial development, market demand, product pipelines, technological innovation, etc., taps into the huge potential for industry development, and tracks the future development trends of the industry.